Search research articles
Contact Us
Filters
Showing results (351-360 of 420) with videos related to
Page
of 42
Sort By:
Urologic Oncology
|
August 7, 2022
Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomy
Alexander P Kenigsberg, Gianpaolo Carpinito, Samuel A Gold, et al.
Journal of Basic and Clinical Physiology and Pharmacology
|
January 3, 2026
Serum copper, rubidium, selenium, strontium, and zinc and psychophysical health in adults of the Sarno river Basin: PREVES-STOP 2025 community biomonitoring results
Luca Scafuri, Raffaele Baio, Carlo Buonerba, et al.
European Radiology
|
March 20, 2024
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models
Giulia Marvaso, Lars Johannes Isaksson, Mattia Zaffaroni, et al.
BJUI Compass
|
January 29, 2025
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data
Anas S Tresh, Francesco Del Giudice, Shufeng Li, et al.
Minerva Urology and Nephrology
|
December 18, 2025
Elevated creatinine-to-hemoglobin ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: analysis from the ROBUUST registry
Margaret F Meagher, Clara Cerrato, Mimi V Nguyen, et al.
Central European Journal of Urology
|
January 27, 2022
Influence of operative time and blood loss on surgical margins and functional outcomes for laparoscopic versus robotic-assisted radical prostatectomy: a prospective analysis
Stefano Salciccia, Davide Rosati, Pietro Viscuso, et al.
Urologic Oncology
|
September 20, 2025
The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BCG): Analysis of USA insurance claim data
Francesco Del Giudice, Valerio Santarelli, Jan Łaszkiewicz, et al.
The Journal of Urology
|
April 21, 2021
Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration)
Andrew B Katims, Rollin Say, Ithaar Derweesh, et al.
Oncology
|
September 29, 2025
Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Giuseppe Di Lorenzo, Antonio Verde, Luca Scafuri, et al.
The Journal of Urology
|
April 4, 2022
Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry
Kevin Hakimi, Umberto Carbonara, Hooman Djaladat, et al.
Page
of 42
Search research articles
Search
Showing results (351-360 of 420) with videos related to
Sort By:
Page
of 42
Urologic Oncology
|
August 7, 2022
Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomy
Alexander P Kenigsberg, Gianpaolo Carpinito, Samuel A Gold, et al.
Journal of Basic and Clinical Physiology and Pharmacology
|
January 3, 2026
Serum copper, rubidium, selenium, strontium, and zinc and psychophysical health in adults of the Sarno river Basin: PREVES-STOP 2025 community biomonitoring results
Luca Scafuri, Raffaele Baio, Carlo Buonerba, et al.
European Radiology
|
March 20, 2024
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models
Giulia Marvaso, Lars Johannes Isaksson, Mattia Zaffaroni, et al.
BJUI Compass
|
January 29, 2025
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data
Anas S Tresh, Francesco Del Giudice, Shufeng Li, et al.
Minerva Urology and Nephrology
|
December 18, 2025
Elevated creatinine-to-hemoglobin ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: analysis from the ROBUUST registry
Margaret F Meagher, Clara Cerrato, Mimi V Nguyen, et al.
Central European Journal of Urology
|
January 27, 2022
Influence of operative time and blood loss on surgical margins and functional outcomes for laparoscopic versus robotic-assisted radical prostatectomy: a prospective analysis
Stefano Salciccia, Davide Rosati, Pietro Viscuso, et al.
Urologic Oncology
|
September 20, 2025
The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BCG): Analysis of USA insurance claim data
Francesco Del Giudice, Valerio Santarelli, Jan Łaszkiewicz, et al.
The Journal of Urology
|
April 21, 2021
Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration)
Andrew B Katims, Rollin Say, Ithaar Derweesh, et al.
Oncology
|
September 29, 2025
Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Giuseppe Di Lorenzo, Antonio Verde, Luca Scafuri, et al.
The Journal of Urology
|
April 4, 2022
Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry
Kevin Hakimi, Umberto Carbonara, Hooman Djaladat, et al.
Page
of 42